| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $14,688,484 ) (Continued on the next page) |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA248018 | Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies | 001 | 4 | NIH | 4/15/2024 | $19,178 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UH3CA260602 | Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting | 002 | 4 | NIH | 4/12/2024 | $2,281,096 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | DP2CA260421 | Decoding the nuclear metabolic processes regulating gene transcription | 000 | 1 | NIH | 2/19/2024 | $20,175 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R37CA279440 | The Immunomodulatory Function of Cyclin E1 in Ovarian Cancer and Therapeutic Targeting | 000 | 1 | NIH | 3/11/2024 | $505,851 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283547 | Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction | 001 | 1 | NIH | 3/14/2024 | -$29,997 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283547 | Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction | 000 | 1 | NIH | 2/26/2024 | $728,484 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA234162 | NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer | 000 | 6 | NIH | 4/12/2024 | $382,429 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UG1CA233191 | Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute | 001 | 6 | NIH | 4/16/2024 | $23,033 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UG1CA233191 | Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute | 000 | 6 | NIH | 2/13/2024 | $414,582 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | U24CA232979 | Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI | 000 | 1 | NIH | 1/29/2024 | $102,886 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA247362 | RB tumor suppressor as a therapeutic target in ER-positive breast cancer | 002 | 5 | NIH | 3/13/2024 | -$182,249 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA247362 | RB tumor suppressor as a therapeutic target in ER-positive breast cancer | 001 | 5 | NIH | 2/20/2024 | $316,204 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA247362 | RB tumor suppressor as a therapeutic target in ER-positive breast cancer | 000 | 5 | NIH | 2/14/2024 | $568,828 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA283501 | MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication | 000 | 1 | NIH | 3/15/2024 | $754,264 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R03CA289559 | Linking lifestyles with tumor immune profiles to identify strategies for improving breast cancer outcomes | 000 | 1 | NIH | 3/1/2024 | $86,750 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R03CA286634 | TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer | 000 | 1 | NIH | 12/6/2023 | $86,750 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA266216 | Induction of interferon response by chromatin damaging anti-cancer therapy | 000 | 1 | NIH | 11/24/2023 | $396,881 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R21CA288931 | Combined inhibition of ATR and p110? as Therapy in PTEN-deficient Prostate Cancer | 000 | 1 | NIH | 2/22/2024 | $202,778 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA272771 | The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer | 000 | 2 | NIH | 3/5/2024 | $390,585 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R03CA280307 | The role of ceramide kinase in metastasis growth from aggressive breast cancer | 000 | 2 | NIH | 4/16/2024 | $86,750 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R35GM148071 | The Genetic Basis of Human DNA Replication Timing | 001 | 2 | NIH | 12/18/2023 | $412,236 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01MH126282 | Investigating how stress induced changes in maternal serotonin affect offspring development and stress resilience | 005 | 4 | NIH | 3/11/2024 | $386,325 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01ES034250 | STAG2 modulates environmental toxicant exposures and epigenomic heterogeneity | 000 | 3 | NIH | 12/19/2023 | $597,213 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 002 | 3 | NIH | 4/16/2024 | $11,705 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 001 | 3 | NIH | 12/15/2023 | $210,658 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA258337 | Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence | 000 | 3 | NIH | 12/1/2023 | $588,984 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R37CA275961 | Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma | 000 | 2 | NIH | 1/9/2024 | $425,943 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA252092 | Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer | 001 | 4 | NIH | 3/1/2024 | $57,061 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA252092 | Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer | 000 | 4 | NIH | 2/29/2024 | $321,999 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | U01CA256801 | Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer | 003 | 4 | NIH | 4/16/2024 | $35,339 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | U01CA256801 | Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer | 002 | 4 | NIH | 4/2/2024 | $636,101 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01AI155499 | Understanding mechanisms and consequences of T cell co-receptor regulated RNA maturation | 000 | 4 | NIH | 3/5/2024 | $465,229 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA255242 | Advancing skin cancer prevention by tackling UV-induced clonogenic mutations | 000 | 4 | NIH | 1/19/2024 | $538,310 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA251545 | Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer | 000 | 4 | NIH | 2/13/2024 | $549,186 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | K08CA252161 | Therapeutic implication of RB1 loss in bladder cancer | 000 | 4 | NIH | 2/9/2024 | $285,729 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01CA243456 | Radiogenomic Credentialing of Head and Neck Cancer Models | 001 | 4 | NIH | 4/15/2024 | $29,087 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA243456 | Radiogenomic Credentialing of Head and Neck Cancer Models | 000 | 4 | NIH | 11/9/2023 | $523,581 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01HL150266 | Inhibition of Radiation-Induced Coronary Microvascular Disease | 000 | 4 | NIH | 12/18/2023 | $370,188 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA250412 | Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity | 000 | 4 | NIH | 12/18/2023 | $627,450 |
| | 2024 | 2024 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R37CA248018 | Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies | 000 | 4 | NIH | 11/8/2023 | $345,207 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | UH3CA260602 | Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting | 001 | 3 | NIH | 2/9/2024 | $23,578 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | UH3CA260602 | Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting | 000 | 3 | NIH | 11/20/2023 | $0 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01CA251198 | Sensitizing high grade serous cancers to immunotherapy through the induction of DNA damage | 000 | 5 | NIH | 12/20/2023 | $0 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | P50CA159981 | Roswell Park Ovarian Cancer SPORE | 001 | 9 | NIH | 3/18/2024 | $0 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | P50CA159981 | Roswell Park Ovarian Cancer SPORE | 002 | 9 | NIH | 3/21/2024 | $0 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | P50CA159981 | Roswell Park Ovarian Cancer SPORE | 000 | 9 | NIH | 11/9/2023 | $0 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01DA057228 | Assessing pharmacokinetic and pharmacodynamic variability of ?9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine | 000 | 2 | NIH | 2/27/2024 | $0 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | 665 ELM ST | BUFFALO | NY | 14203-1104 | ERIE | USA | R01MH126282 | Investigating how stress induced changes in maternal serotonin affect offspring development and stress resilience | 004 | 3 | NIH | 12/12/2023 | $96,628 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | ELM & CARLTON ST | BUFFALO | NY | 14263-0001 | ERIE | USA | R01MH126282 | Investigating how stress induced changes in maternal serotonin affect offspring development and stress resilience | 001 | 3 | NIH | 11/9/2023 | $429,250 |
|
| Loading… |
|
